Invention Grant
- Patent Title: Pharmaceutical uses of pyridine carboxamide derivatives
-
Application No.: US16257484Application Date: 2019-01-25
-
Publication No.: US10759788B2Publication Date: 2020-09-01
- Inventor: Xin Li , Qing Dong , Piaoyang Sun
- Applicant: Jiangsu Hengrui Medicine Co., Ltd. , Shanghai Hengrui Pharmaceutical Co., Ltd.
- Applicant Address: CN Lianyungang, Jiangsu CN Shanghai
- Assignee: JIANGSU HENGRUI MEDICINE CO., LTD.,SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
- Current Assignee: JIANGSU HENGRUI MEDICINE CO., LTD.,SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Lianyungang, Jiangsu CN Shanghai
- Agency: Ice Miller LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@15b73e20
- Main IPC: C07D405/14
- IPC: C07D405/14 ; A61K31/4545 ; C07D401/12

Abstract:
Pharmaceutical uses of pyridinecarboxamide derivatives are provided. In particular, pharmaceutical uses of pyridinecarboxamide derivatives represented by general formula (I), wherein the substituents of the formula (I) are defined in the specification, are provided. The pyridinecarboxamide derivatives can be used as therapeutic agents, especially as inhibitors of the Renal Outer Medullary Potassium channel (ROMK) and in the preparation of medicaments for treating and/or preventing ROMK mediated disorders, such as hypertension and heart failure.
Public/Granted literature
- US20190152958A1 PHARMACEUTICAL USES OF PYRIDINE CARBOXAMIDE DERIVATIVES Public/Granted day:2019-05-23
Information query